These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 12126571

  • 1. [Experimental study on adenovirus-mediated transfer of p53 or adenovirus- mediated transfer of p53 combined with radiotherapy for human cervical cancer cell line HeLa cells].
    Kong W, Sun J, Lin C, Zha Y, Lu G, Fu M, Zhang X.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun 18; 37(6):352-5. PubMed ID: 12126571
    [Abstract] [Full Text] [Related]

  • 2. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
    Zhang Y, Lin C, Qian HL, Lang JH, Fu M, Zhang XY, Liang X, Duan H, Xiang Y.
    Zhonghua Zhong Liu Za Zhi; 2007 Jan 18; 29(1):25-9. PubMed ID: 17575689
    [Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr 18; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X, Chang Z, Song J, Gao G, Shen Z.
    Anticancer Drugs; 2011 Jul 18; 22(6):556-62. PubMed ID: 21637162
    [Abstract] [Full Text] [Related]

  • 6. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.
    Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus carrying TIMP-3: a potential tool for cervical cancer treatment.
    Zhang Y, Qian H, Lin C, Lang J, Xiang Y, Fu M, Zhang X, Liang X.
    Gynecol Oncol; 2008 Jan 01; 108(1):234-40. PubMed ID: 17976707
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
    Modesitt SC, Ramirez P, Zu Z, Bodurka-Bevers D, Gershenson D, Wolf JK.
    Clin Cancer Res; 2001 Jun 01; 7(6):1765-72. PubMed ID: 11410518
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL, Dell J, Maxwell E, Armstrong L, Maneval D, Catino JJ.
    Cancer Gene Ther; 1997 Jun 01; 4(2):129-38. PubMed ID: 9080122
    [Abstract] [Full Text] [Related]

  • 10. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
    Zuo ZH, Zhao M, Liu J, Wei Y, Wu XX.
    Ai Zheng; 2006 Jul 01; 25(7):811-7. PubMed ID: 16831269
    [Abstract] [Full Text] [Related]

  • 11. [Inhibition of tongue cancer development in nude mice transfected with adenovirus carrying human endostatin gene].
    Ding XQ, Chen Y, Li L, Liu RY, Huang JL, Lai K, Wu XJ, Ke ML, Huang WL.
    Ai Zheng; 2003 Nov 01; 22(11):1152-7. PubMed ID: 14613642
    [Abstract] [Full Text] [Related]

  • 12. Bladder cancer therapy using combined proliferating cell nuclear antigen antisense oligonucleotides and recombinant adenovirus p53.
    Zhu Z, Xing S, Lin C, Zhang X, Fu M, Liang X, Zeng F, Lu G, Wu M.
    Chin Med J (Engl); 2003 Dec 01; 116(12):1860-3. PubMed ID: 14687474
    [Abstract] [Full Text] [Related]

  • 13. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R, Phillips E, Hooper R, Wilson D, Partridge M.
    Clin Cancer Res; 2002 Jun 01; 8(6):1984-94. PubMed ID: 12060644
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
    Nguyen DM, Wiehle SA, Koch PE, Branch C, Yen N, Roth JA, Cristiano RJ.
    Cancer Gene Ther; 1997 Jun 01; 4(3):191-8. PubMed ID: 9171938
    [Abstract] [Full Text] [Related]

  • 17. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
    Dong YB, Yang HL, McMasters KM.
    Cancer Gene Ther; 2003 Mar 01; 10(3):168-78. PubMed ID: 12637937
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
    Hamada K, Alemany R, Zhang WW, Hittelman WN, Lotan R, Roth JA, Mitchell MF.
    Cancer Res; 1996 Jul 01; 56(13):3047-54. PubMed ID: 8674061
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.
    Ghaneh P, Greenhalf W, Humphreys M, Wilson D, Zumstein L, Lemoine NR, Neoptolemos JP.
    Gene Ther; 2001 Feb 01; 8(3):199-208. PubMed ID: 11313791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.